• LAST PRICE
    4.9800
  • TODAY'S CHANGE (%)
    Trending Down-0.0800 (-1.5810%)
  • Bid / Lots
    4.9500/ 3
  • Ask / Lots
    6.0000/ 10
  • Open / Previous Close
    5.0900 / 5.0600
  • Day Range
    Low 4.9000
    High 5.1298
  • 52 Week Range
    Low 3.2200
    High 12.3007
  • Volume
    121,244
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 5.06
TimeVolumeSMMT
09:32 ET167385.09
09:34 ET76375.08
09:36 ET40715.04
09:38 ET5005.01
09:39 ET22574.9664
09:41 ET40054.9653
09:43 ET5464.9
09:45 ET10004.9079
09:48 ET10004.9202
09:50 ET7034.91
09:59 ET2004.96
10:08 ET4004.9225
10:10 ET1004.9349
10:12 ET1004.9288
10:14 ET27004.95
10:19 ET3004.97
10:21 ET14164.98
10:35 ET18264.9798
10:42 ET2154.995
10:55 ET3004.99
11:00 ET6005.01
11:04 ET1005.015
11:09 ET1005.0313
11:11 ET10005.07
11:15 ET1005.04
11:29 ET1005.02
11:31 ET3005.05
11:36 ET5005.04
11:45 ET8004.99
12:12 ET2504.99
12:14 ET15985
12:16 ET1005
12:18 ET1005
12:23 ET1005
12:27 ET1005.02
12:32 ET1005.02
12:34 ET10005.029
12:41 ET88435.03
12:48 ET1004.99
12:50 ET1004.98
12:52 ET3005.02
12:54 ET3004.99
12:56 ET1004.99
12:57 ET2004.99
12:59 ET1004.99
01:03 ET2004.99
01:12 ET1005.005
01:14 ET4005.005
01:17 ET1004.9942
01:19 ET3375.005
01:21 ET2005.005
01:24 ET1004.99
01:28 ET2455.005
01:37 ET1004.99
01:39 ET3005.02
01:44 ET11005.02
01:55 ET2005.005
02:00 ET1005.01
02:02 ET16154.99
02:06 ET9334.99
02:08 ET5004.99
02:13 ET24635
02:27 ET1004.99
02:31 ET1005
02:36 ET8005.01
02:38 ET1005.015
02:51 ET1005
02:58 ET3005.01
03:12 ET2005.01
03:16 ET4365
03:18 ET1235.015
03:20 ET3465
03:23 ET5004.99
03:32 ET6005.01
03:34 ET137244.985
03:36 ET14554.98
03:41 ET13774.98
03:43 ET3004.975
03:48 ET14004.965
03:50 ET6004.98
03:52 ET1004.98
03:54 ET40204.97
03:56 ET8564.98
03:57 ET5004.96
03:59 ET82304.98
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSMMT
Summit Therapeutics Inc
485.0M
-5.4x
---
United StatesKDNY
Chinook Therapeutics Inc
488.3M
-1.7x
---
United StatesBOLT
Bolt Biotherapeutics Inc
483.2M
-4.6x
---
United StatesPASG
Passage Bio Inc
482.5M
-2.8x
---
United StatesCVM
CEL-SCI Corp
491.4M
-13.3x
---
United StatesBLU
BELLUS Health Inc
487.9M
-9.8x
---
As of 2021-10-23

Company Information

Summit Therapeutics Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing novel antibiotics for serious infectious diseases. Its lead CDI product candidate is ridinilazole is an orally administered small molecule antibiotic. The Company's preclinical candidates include SMT-738, from the DDS-04 series for development in the fight against multidrug-resistant infections, specifically carbapenem-resistant Enterobacteriaceae (CRE) infections. The Company is conducting a Phase III clinical program focused on the infectious disease C. difficile infection (CDI). The Company is also seeking to expand its product candidate portfolio through the development of a new mechanism, precision antibiotics using its proprietary Discuva Platform.

Contact Information

Headquarters
One Broadway, 14Th FloorCAMBRIDGE, MA, United States 02142
Phone
617-514-7149
Fax
302-655-5049

Executives

Executive Chairman of the Board, Chief Executive Officer
Robert Duggan
Chief Financial Officer
Michael Donaldson
Chief Operating Officer, Director
Mahkam Zanganeh
Chief Scientific Officer
David Powell
Director
Kenneth Clark

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$485.0M
Revenue (TTM)
$615.0K
Shares Outstanding
97.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.94
EPS
$-0.92
Book Value
$0.96
P/E Ratio
-5.4x
Price/Sales (TTM)
788.6
Price/Cash Flow (TTM)
---
Operating Margin
-11,775.28%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.